Recall D-0608-2025

US Class II Ongoing · initiated 2025-07-09

Recalling firm

Boothwyn Pharmacy LLC, PA

Product

Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy

Reason for recall

Subpotent Drug

← All recalls